Cinnamaldehyde Inhibits The Cell Proliferation And Migration Of Triple-Negative Breast Cancer Cells By Inhibiting P-Jak2/P-Stat3 Signaling Pathway

Lijun Zhang,Ying Dai,Yuanhua Zhou,Haiyan Qiu,Yuanyuan Jiang
DOI: https://doi.org/10.1166/jbt.2020.2461
2020-01-01
Journal of Biomaterials and Tissue Engineering
Abstract:Triple-negative breast cancer (TNBC) is one major type of breast cancer with no specific target for the effective treatment. Cinnamaldehyde (CA, C6H5CH = CHCHO) exhibits inhibitory effects on numerous cancer types. We aimed to explore the potential function of CA in TNBC, and the molecules that were responsible for the function of CA in TNBC. Real time quantitative PCR (RT-qPCR) and western blot were carried out for the determination of mRNA as well as protein expression levels, respectively. Cell count kit-8 (CCK-8) and wound healing assay were carried out to determine cell proliferation ability and cell migration ability, respectively. Herein, CA was observed to dramatically suppress cell proliferative and cell migration abilities of MDA-MB-231 cells. Furthermore, Cyclin D1, vascular endothelial growth factor (VEGF) and matrix metalloproteinase 2 (MMP2) levels were remarkably dose-dependently decreased by CA; while tissue inhibitor of metalloproteinase-3 (TIMP3) level was dose-dependently increased by CA. At last, phosphorylated levels of janus kinase 2 (p-JAK2) and signal transducer and activator of transcription (p-STAT3) were significantly dose-dependently decreased by CA (40 and 80 mu g/ml). Therefore, our data clearly demonstrated that, CA repressed cell proliferation ability and cell migration ability of TNBC through inactivating p-JAK2/p-STAT3, thus suggesting the possibility of CA in treating patients with TNBC.
What problem does this paper attempt to address?